Patient Pathfinder: Clinical Trials
Clinical Trials for Multiple Sclerosis
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 295 active Multiple Sclerosis trials
Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy
Study Type: Interventional Phase 4
Online Program to Reduce Depression in MS
Study Type: Interventional
Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue
Study Type: Interventional Phase 1
9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis
Study Type: Interventional Phase 3
iConquerMS™ – A Patient-Powered Research Network for Multiple Sclerosis
Study Type: Observational
A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab
Study Type: Interventional Phase 4
Novel Assessment of Synaptic Density in Progressive MS
Study Type: Interventional Early Phase 1
Biobank For MS And Other Demyelinating Diseases
Study Type: Observational
There are 295 active Multiple Sclerosis trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now